Treatment Patterns and Patient Reported Outcomes in Benign Prostatic Hyperplasia Patients with Overactive Bladder Symptoms

Overactive Bladder ◽

Patient Reported Outcomes ◽

Treatment Patterns ◽

Prostatic Hyperplasia ◽

Patient Reported ◽

Solifenacin or Mirabegron Could Improve Persistent Overactive Bladder Symptoms After Dutasteride Treatment in Patients With Benign Prostatic Hyperplasia

Urology ◽

10.1016/j.urology.2015.01.028 ◽

2015 ◽

Vol 85 (5) ◽

pp. 1151-1155 ◽

Cited By ~ 10

Author(s):

Takahiro Maeda ◽

Eiji Kikuchi ◽

Masanori Hasegawa ◽

Katsura Ishioka ◽

Masayuki Hagiwara ◽

...

Keyword(s):

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Patient Reported Outcomes(Pros) in Patients with Lower Urinary Track Symptom(Luts)/Benign Prostatic Hyperplasia(Bph) Accompanied with Overactive Bladder(Oab) in Korea

Value in Health ◽

10.1016/j.jval.2014.08.561 ◽

2014 ◽

Vol 17 (7) ◽

pp. A812

Author(s):

J.Y. Lee ◽

Y.H. Park ◽

Y.J. Kim

Keyword(s):

Overactive Bladder ◽

Patient Reported Outcomes ◽

Prostatic Hyperplasia ◽

Patient Reported ◽

Lower Urinary

LBA-03 EFFICACY AND SAFETY OF MIRABEGRON VS. PLACEBO ADD-ON THERAPY IN MEN WITH OVERACTIVE BLADDER SYMPTOMS RECEIVING TAMSULOSIN FOR UNDERLYING BENIGN PROSTATIC HYPERPLASIA (PLUS)

The Journal of Urology ◽

10.1097/01.ju.0000557495.41260.09 ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

Steven Kaplan* ◽

Sender Herschorn ◽

Kevin McVary ◽

David Staskin ◽

Christopher Chapple ◽

...

Keyword(s):

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT - a double-blind, placebo-controlled trial

International Journal of Clinical Practice ◽

10.1111/j.1742-1241.2009.02209.x ◽

2009 ◽

Vol 63 (12) ◽

pp. 1702-1714 ◽

Cited By ~ 38

Author(s):

M. D. Vardy ◽

H. D. Mitcheson ◽

T.-A. Samuels ◽

J. D. Wegenke ◽

S. Forero-Schwanhaeuser ◽

...

Keyword(s):

Overactive Bladder ◽

Patient Reported Outcomes ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Symptom Bother ◽

Patient Reported ◽

Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open-label, controlled trial (DIrecT Study)

International Journal of Urology ◽

10.1111/iju.13359 ◽

2017 ◽

Vol 24 (7) ◽

pp. 525-531 ◽

Cited By ~ 11

Author(s):

Tomonori Yamanishi ◽

Hirotaka Asakura ◽

Narihito Seki ◽

Shoji Tokunaga

Keyword(s):

Overactive Bladder ◽

Combination Therapy ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Open Label ◽

Direct Study ◽

Effect of systemic atherosclerosis on overactive bladder symptoms in men with benign prostatic hyperplasia

LUTS Lower Urinary Tract Symptoms ◽

10.1111/luts.12406 ◽

2021 ◽

Author(s):

Dongu Lee ◽

Kyo Chul Koo ◽

Jeong Woo Yoo ◽

Kwang Suk Lee

Keyword(s):

Overactive Bladder ◽

Prostatic Hyperplasia ◽

MP-01.01: The effect of anticholinergics to benign prostatic hyperplasia patients with overactive bladder symptoms and the risk factors to affect patient's satisfaction

Urology ◽

10.1016/j.urology.2010.07.345 ◽

2010 ◽

Vol 76 (3) ◽

pp. S9

Author(s):

W. Cho ◽

T. Kim ◽

J. Yoon

Keyword(s):

Risk Factors ◽

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Patient’S Satisfaction ◽

Efficacy of adding mirabegron to alpha-adrenoreceptor blocker in patients with benign prostatic hyperplasia with persistent overactive bladder symptoms: A prospective study

Investigative and Clinical Urology ◽

10.4111/icu.2020.61.4.419 ◽

2020 ◽

Vol 61 (4) ◽

pp. 419

Author(s):

Se Yun Kwon ◽

Dong Jin Park ◽

Young Jin Seo ◽

Kyung Seop Lee

Keyword(s):

Overactive Bladder ◽

Prospective Study ◽

Prostatic Hyperplasia ◽

Bladder Symptoms ◽

A Prospective Study

Clinical efficacy of an α1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia

International Journal of Urology ◽

10.1111/j.1442-2042.2006.01222.x ◽

2006 ◽

Vol 13 (1) ◽

pp. 15-20 ◽

Cited By ~ 37

Author(s):

SATORU TAKAHASHI ◽

ATSUSHI TAJIMA ◽

HISASHI MATSUSHIMA ◽

TAKESHI KAWAMURA ◽

TAKASHI TOMINAGA ◽

...

Keyword(s):

Overactive Bladder ◽

Clinical Efficacy ◽

Prostatic Hyperplasia ◽

Adrenoceptor Blocker ◽

Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study

Urology ◽

10.1016/j.urology.2020.09.040 ◽

2021 ◽

Vol 147 ◽

pp. 235-242

Author(s):

Sender Herschorn ◽

Kevin T. McVary ◽

Javier Cambronero Santos ◽

Steve Foley ◽

Rita M. Kristy ◽

...

Keyword(s):

Overactive Bladder ◽

Safety Analysis ◽

Prostatic Hyperplasia ◽